Kristen Yen - Jan 25, 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Officer title: Vice President, Clinical Operations
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Jan 25, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 05:12 PM
Previous filing
Oct 14, 2022
Next filing
May 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Award $0 +20K $0.00 20K Jan 25, 2023 Common Stock 20K $2.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth of the shares subject to the option shall vest on February 1, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.

Remarks:

Officer title: Vice President, Clinical Operations